Po-telmisartan/hctz (2017-05-02)
Apo-Telmisartan/HCTZ Recall Summary Apo-Telmisartan/HCTZ, a blood pressure medication, has been recalled in Canada due to product safety concerns. The recall is classified as Class I, meaning there is a serious potential health risk. The affected product was distributed across Canada.
- Reason
- Product safety
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2017-06-22
- Status
- Closed
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/07b04552-f09b-44cb-bac5-bfb4acd11afb